| HS Code | 334325 |
| Product Name | Meat Proteolytic Enzyme |
| Enzyme Type | Protease |
| Source | Bacillus subtilis |
| Main Function | Hydrolyzes meat proteins to improve tenderness |
| Optimal Temperature | 50-60°C |
| Optimal Ph | 6.0-7.5 |
| Enzyme Activity | 100,000 U/g |
| Physical Form | Powder |
| Solubility | Water-soluble |
| Recommended Dosage | 0.1-0.5% by weight of meat |
| Storage Conditions | Store in a cool, dry place |
| Shelf Life | 12 months |
As an accredited Meat Proteolytic Enzyme factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Meat Proteolytic Enzyme is supplied in 20 kg sealed polyethylene-lined fiber drums with tamper-evident lids, stored cool and dry. |
| Container Loading (20′ FCL) | 20′ FCL: palletized drums of Meat Proteolytic Enzyme securely loaded, ventilated, moisture-protected, with proper labeling and segregation per shipping regulations. |
| Shipping | Meat Proteolytic Enzyme ships as a non-hazardous, temperature-sensitive biochemical. Pack in sealed, food-grade containers, protect from moisture and heat, and label as “Enzyme Preparation.” Use standard dry-ice or chilled transport if required, with clear handling instructions to prevent inactivation. No UN dangerous goods classification applies unless otherwise specified. |
| Storage | Store Meat Proteolytic Enzyme in a tightly sealed, moisture-proof container in a cool, dry place, ideally refrigerated at 2–8°C (35–46°F). Protect from direct sunlight, heat, and humidity, which can reduce activity. Avoid repeated temperature fluctuations. Under proper conditions, the enzyme remains stable and effective for its intended shelf life. |
| Shelf Life | Store at 2-8°C, protected from moisture and light. Shelf life typically 12 months from manufacture date. |
Injection of a dilute papain or bromelain preparation into intact beef forequarter muscles is carried out before vacuum tumbling to reduce connective tissue toughness without thermal denaturation. The brine is formulated at 2.0% w/w sodium chloride, 0.3% w/w sodium tripolyphosphate, and 0.05–0.10% w/w enzyme preparation on green weight. A multi-needle injector set to 12–15% green weight pickup distributes the solution through the epimysium and perimysium. The injected muscles are transferred to a vacuum tumbler operated at −0.08 MPa, 6–8 rpm, and 40–80 min, with jacket cooling maintaining ≤4°C. Shear force is measured on cores of 1.27 cm diameter cooked to 71°C internal on a TA.XT Plus texture analyzer fitted with a Warner-Bratzler blade at 200 mm/min crosshead speed. Enzymatic activity continues during an overnight hold at 0–4°C for 12–16 h; the rate is suppressed below pH 5.0 and accelerated between pH 5.8 and 7.0.
Control of needle clogging is a production bottleneck. The enzyme powder is pre-hydrated at 20°C for 10 min and passed through a 250 µm mesh before brine addition. Without this step, multi-needle injectors show pressure rise above 2 bar and uneven lateral distribution across the muscle bed. Overdosing above 0.3% w/w or holding beyond 18 h produces visible surface digestion and purge loss exceeding 5% in vacuum packs, particularly in muscles with pH above 5.9. Compliance in the United States requires the enzyme source to be listed in 21 CFR part 184, with papain under 21 CFR 184.1585 and bromelain under 21 CFR 184.1024. In the European Union, the enzyme must be authorized under Regulation (EC) No 1332/2008, and finished-product labelling follows Regulation (EU) No 1169/2011 unless the enzyme qualifies as a processing aid. Thermal inactivation is not immediate below 60°C, so sous-vide pasteurization at low internal temperature must be validated for residual protease activity before packaging.
In restructured muscle systems, a narrow dosage window separates tenderness from binding failure because the enzyme contacts both connective tissue and the salt-soluble myosin tail that must form a heat-set bind. When the enzyme load exceeds 0.03% of extracted salt-soluble protein, cleavage at lysine and arginine residues reduces the number of intact myosin tails available for heat-induced network formation. The practical consequence is loss of bind at the muscle-piece interface, cavity formation during slicing, and purge in vacuum packs. Brines are typically set to 2.5% sodium chloride and 0.4% sodium tripolyphosphate, with enzyme dose at 0.01–0.03% of extracted protein. The tumbling sequence uses 10 rpm at 4°C for 2 h. The stuffed product is cooked to 72°C internal and chilled to 4°C before slicing. Gel strength can be measured as the force at 70% compression using a texture analyzer with a 50 mm diameter cylinder; an intact restructured product normally exhibits a cohesive slice without visible seams.
The interaction with phosphate is not independent. Phosphate increases ionic strength and extracts myofibrillar proteins, but it also increases the available substrate that the enzyme can cleave. Equipment suppliers therefore instruct that phosphate be fully dissolved before enzyme addition and that brine temperature not exceed 4°C until injection. If enzyme powder is added directly to a high-ionic-strength brine, local concentration spikes yield soft spots that are detected only after cooking. In HACCP records, residual activity after the cook step should be below the limit of detection. If residual activity is present, the product cannot be labelled as an enzyme-treated processing aid in markets that require inactivation. Published data for this specific configuration is limited, and process validation is generally performed with a controlled dosage ladder on a single raw material lot. In the United States, the final product remains subject to the preparation and processing operations requirements of 9 CFR part 424.
Hydrolysis of trimmings, mechanically separated meat, and neck bone residuals for liquid seasonings is performed in a jacketed stirred-tank reactor with pH-stat control. Substrate is ground to 5 mm, suspended in potable water to a slurry containing 12–15% crude protein, and adjusted to pH 6.5–7.5 with food-grade sodium hydroxide. The enzyme is added at 0.5–1.5% of total protein, and the reaction is held at 50–60°C for 2–6 h. Inactivation is carried out at 90°C for 10 min. The hydrolysate is then separated in a decanter centrifuge at 4,000 × g, clarified through a spiral-wound ultrafiltration membrane with a 10 kDa molecular weight cut-off, and concentrated before spray drying. The end product is a low-fat savory base powder used in bouillon cubes, liquid seasonings, and dry soup mixes. Subsequent Maillard reaction at 100°C for 20–40 min with xylose and cysteine generates roasted meat notes.
Hydrophobic peptides below 1,000 Da are associated with bitterness. Controlled hydrolysis therefore limits degree of hydrolysis below 25% unless an aminopeptidase is dosed in a second reactor. Batch records include amino nitrogen by formol titration and total nitrogen by ISO 937:2023. Microbiological limits for the final dry product must comply with Regulation (EC) No 2073/2005; typical release checks include Enterobacteriaceae absence in 1 g and Listeria monocytogenes absence in 25 g. In the EU, enzyme use must comply with Regulation (EC) No 1332/2008. If the hydrolysate is used as a flavoring preparation, the final flavor must comply with Regulation (EC) No 1334/2008. Batch-to-batch variance in starting connective tissue content shifts the required enzyme dose, so operators typically adjust dosage against a daily amino nitrogen target rather than using a fixed addition rate.
During wet pet food manufacturing, proteolytic enzyme treatment is applied to poultry frames, liver slurries, and mechanically separated beef and pork residues to reduce retort strainer blockages and increase gravy yield before canning. The substrate is a by-product slurry at 30–35% dry matter, pH 5.8–6.5, and the enzyme is dosed at 0.05–0.2% w/w fresh substrate. Hydrolysis takes place in a scraped-surface cooker with steam jacket temperature 55°C and residence time 60–120 min. The cooked slurry is blended into the final loaf or gravy phase at 10–15% of fill weight, sealed in 300 g cans, and retorted at 121°C for 50 min with accumulated lethality verified by F₀ calculation from thermocouple data. The enzyme step reduces the strainer residue fraction that would otherwise block filling nozzles and accelerates recirculation pump flow through the filling line.
Digestibility improvement is measured by the pepsin-HCl method referenced as AOAC 971.09. Hydrolysates produced under the upper half of the dosage window can show increased pepsin digestibility relative to untreated by-product slurry. In EU operations, an enzyme used as a feed additive requires authorization under Regulation (EC) No 1831/2003, while animal by-product handling must satisfy Regulation (EC) No 1069/2009 and validated inactivation in the HACCP plan. Operators must confirm that enzyme activity does not survive retort. If activity is intentionally retained as a feed additive, the final product requires additive labelling and quantity statements on the label. Steam-jacket overheating above 65°C during hydrolysis denatures the enzyme before the desired degree of hydrolysis is reached. Insufficient mixing at 25–30 rpm causes localized gelation at the wall and burned-on residues that are detected only at cleaning-in-place inspection.
| Downstream matrix | Protease addition window | pH and temperature boundary | Critical endpoint or failure mode |
|---|---|---|---|
| Whole-muscle beef | 0.05–0.10% w/w green weight | pH 5.0–5.8, ≤4°C | Surface digestion after 18 h; purge > 5% |
| Restructured muscle bind | 0.01–0.03% of extracted protein | pH 5.2–5.8, 4°C | Loss of sliceability, seam cavities |
| Meat protein hydrolysate | 0.5–1.5% of total protein | pH 6.5–7.5, 50–60°C | Bitterness above 25% degree of hydrolysis |
| Pet food by-product slurry | 0.05–0.2% w/w fresh substrate | pH 5.8–6.5, 55°C | Wall gelation, incomplete retort inactivation |
For connective tissue-rich by-products such as hide trimmings, tendons, and ear skin, a sequential proteolytic digestion is used to release collagen fragments without destroying the triple-helix structure. Raw tissue is ground to 10 mm, suspended in water at 1:2 tissue-to-water ratio, adjusted to pH 6.0–7.0, and dosed with 0.1–0.5% enzyme w/w. The reaction is held at 50–55°C for 60–180 min with intermittent agitation, then heated to 80°C to solubilize gelatin. The extract is clarified through a 20 µm screen and a disc stack centrifuge at 7,000 × g, followed by activated carbon treatment at 0.5% w/w for 60°C for 30 min. Spray drying at 180°C inlet and 85°C outlet produces a gelatin hydrolysate powder. Molecular weight distribution is checked by size-exclusion chromatography. Excessive endoprotease activity can cleave the characteristic collagen α-chain region and reduce bloom strength, so the digestion endpoint is set by viscosity measured on a Brookfield viscometer at 60 rpm.
Food-grade collagen or gelatin derived from animal by-products must be sourced and processed in accordance with Regulation (EC) No 853/2004 and Regulation (EC) No 1069/2009. If the hydrolysate is placed on the EU market as a food supplement ingredient, Directive 2002/46/EC and Regulation (EU) No 2017/2470 may apply depending on the novelty assessment of the specific material. Published data for this specific configuration is limited, particularly for hides with high fat content because free fatty acids generate foam during spray drying and reduce bulk density below 0.25 g/cm³. Operators typically pre-wash fatty tissue at 60°C with a food-grade surfactant before enzyme addition to reduce lipid carryover into the final powder.
Only after a controlled pilot trial is an exogenous protease introduced into dry-cured whole-muscle products because the long ripening time allows even small residual activity to accumulate texture damage. If used, the enzyme is injected into the green ham at 0.01–0.05% by green weight immediately after cooling, at internal pH 5.2–5.8 and temperature 4–7°C. The subsequent salting and resting phase is held at 4°C for 7–14 days, then the product is dried at 12–15°C and 75–80% relative humidity over several weeks. Water activity declines from 0.92 to 0.85, which does not fully inactivate the enzyme but reduces diffusion and substrate mobility. The intended outcome is accelerated release of small peptides and free amino acids that contribute to the cured flavor profile. The process failure mode is local over-hydrolysis in the injection zone, leading to soft paste textures at the center, cavities, and rancid off-notes during prolonged drying.
Because of this risk, many dry-cured ham and fermented sausage manufacturers use exogenous protease only on trimmings or co-products, not on whole retail cuts. Products under protected designations may prohibit the practice entirely, and processors must consult the product specification approved under Regulation (EU) No 1151/2012. In U.S. inspected plants, any enzyme used in dry-cured whole-muscle products must be identified in the HACCP plan and cannot be used to mask spoilage. The product remains subject to the sanitation and process control requirements of 9 CFR part 416 and 9 CFR part 417. Published data for this specific configuration is limited; no validated reduction in aging time should be claimed without a controlled pilot trial on the target raw material and environmental chamber settings.
Competitive Meat Proteolytic Enzyme prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Meat Proteolytic Enzyme product MPE-PF-01 is a standardized enzyme preparation intended for controlled hydrolysis of myofibrillar and connective tissue proteins in whole-muscle, restructured, and marinated meat systems. The preparation is a buffered blend of papain and bromelain standardized on a dextrin carrier to a nominal activity of 1,000,000 PU/g determined by the Food Chemicals Codex casein digestion assay. The product is supplied as a free-flowing powder with particle size distribution not exceeding 180 μm cumulative retention on 95% by weight. This formulation is distinguished from single-protease tenderizers by its dual cysteine-protease activity, which broadens accessible cleavage sites across both actomyosin complexes and collagen fibrils. Because the product is standardized to a narrow activity range, formulation changes in marinade salt content or phosphate level require revalidation of the enzyme-to-substrate ratio.
Post-rigor meat presents a heterogeneous substrate: myofibrillar proteins are embedded within sarcoplasmic fluid, while connective tissue sheaths insulate muscle fiber bundles. MPE-PF-01 activity depends on diffusion of the enzyme into the extracellular matrix and on the availability of cleaved peptide bonds at pH 5.5–6.2. The papain component preferentially hydrolyzes peptide bonds involving lysine, arginine, and phenylalanine residues; bromelain broadens cleavage at glycine, alanine, and tyrosine motifs. Because both enzymes are cysteine proteases, their catalytic activity requires a reducing environment. In intact muscle, residual glutathione and free thiol groups maintain the active-site thiolate form; in brines containing strong oxidants such as hydrogen peroxide, activity declines by more than 50% within 30 min at 4 °C when measured by the FCC casein digestion method. This oxidative sensitivity introduces a critical control point in lines where sanitizer carryover can enter the brine recirculation loop.
Diffusion-limited hydrolysis is observed in cuts with substantial epimysial coverage, where enzyme penetration into the interior is slower than surface diffusion. In brine suspension at 0.1% w/w, the effective diffusion front advances approximately 2–4 mm per 24 h at 4 °C in porcine longissimus tissue, based on manufacturer injection-matrix studies using azocasein staining. This gradient produces a tenderized outer zone and a firmer interior unless injection needles penetrate at intervals not exceeding 25 mm. In whole-muscle systems, the rate-limiting parameter is therefore not the intrinsic catalytic efficiency of the enzyme but the mass transfer of the enzyme from brine phase to the substrate surface.
The release specification for MPE-PF-01 is established from the FCC papain monograph and ISO microbiological methods. Because the product is standardized by addition of dextrin, lot-to-lot activity variance is controlled to ±10% of declared activity. The specification includes a heavy metals limit of ≤10 mg/kg as lead measured by ICP-MS, an arsenic limit of ≤3 mg/kg, and a Salmonella absence criterion of negative per 25 g according to ISO 6579-1:2017. The product is not classified as a processing aid in all jurisdictions; users should verify regulatory status for the intended final label.
| Parameter | Release limit | Test method |
|---|---|---|
| Proteolytic activity (casein digestion) | ≥1,000,000 PU/g | FCC 12 papain activity assay |
| Moisture | ≤8.0% | Vacuum oven loss on drying |
| Particle size | ≥95% through 80 mesh (180 μm) | Sieve analysis |
| Heavy metals (as Pb) | ≤10 mg/kg | ICP-MS after acid digestion |
| Arsenic | ≤3 mg/kg | ICP-MS after acid digestion |
| Total aerobic plate count | ≤50,000 CFU/g | ISO 4833-1:2013 |
| Salmonella | Negative per 25 g | ISO 6579-1:2017 |
In high-fat comminuted systems, MPE-PF-01 use is limited because fat does not serve as a substrate and enzyme activity can hydrolyze interfacial proteins, reducing emulsion stability. At addition levels above 0.2% w/w in sausage emulsions, batter viscosity measured by a rotational viscometer at 4 °C and 10 s⁻¹ shows a decrease of 10–25% after 30 min, increasing the risk of emulsion collapse during thermal processing. The product is therefore not recommended for emulsified meat products unless a structured pilot program confirms acceptable cook stability.
For whole-muscle cuts above 2 kg, uniform introduction of MPE-PF-01 is achieved by multi-needle injection equipment operating at 0.8–1.2 bar brine pressure, followed by vacuum tumbling at −0.8 bar for 20–40 min per 1,000 kg batch. The enzyme is typically suspended in brine at 0.5–2.0 g/L, equivalent to 0.05–0.2% w/w relative to meat block, and held at 2–4 °C for 12–24 h. Higher brine temperatures above 10 °C accelerate hydrolysis but can produce surface over-tenderization; laminar tumbler speed below 12 rpm is recommended to avoid protein extraction that competes with enzymatic cleavage. Shear force reduction measured by Warner-Bratzler method in intramuscular trials reaches 25–40% relative to untreated controls under the 0.1% w/w protocol after 18 h at 4 °C.
In high-shear dispersion, enzyme powder should be prehydrated in water at 20–25 °C for 10 min before introduction into the brine mixer. Direct addition into a running high-shear mixer at 3,000 rpm without prehydration can create localized enzyme concentrations that yield surface depressions in cooked slices. In production-scale vacuum tumblers with load cells, the brine uptake target is 12–18% of green weight; exceeding 22% uptake with enzyme-containing brine may lead to excessive degradation in low-sodium formulations where salt content is below 1.0%. Batch-to-batch variation in meat pH above 0.2 pH units requires adjustment of holding time, because activity at pH 5.4 is approximately 20% lower than at pH 6.0 under the FCC casein assay.
When MPE-PF-01 is compared with single-activity papain powders, the operational distinction is the bromelain fraction. Single papain preparations tend to accumulate hydrophobic peptide fragments associated with bitter taste when hydrolysis exceeds 10% degree of hydrolysis; MPE-PF-01 is formulated to shift hydrolysis toward lower-molecular-weight peptides and free amino acids, reducing this defect. Under identical dosage of 0.1% w/w at 4 °C for 18 h, the preparation yields a more uniform Warner-Bratzler shear force distribution across the cut, with coefficient of variation below 15% compared to 22–28% for papain alone in manufacturer trials. Against bacterial neutral protease preparations, MPE-PF-01 retains activity at the lower meat pH of 5.5–5.8 where neutral proteases often decline; against fungal acid proteases, MPE-PF-01 avoids acid-induced protein denaturation at the surface because brine pH remains above 5.0.
MPE-PF-01 is compatible with sodium chloride concentrations up to 2.5% in the brine phase; salt above 3.0% reduces enzyme activity by 15–30% through ionic strength effects on the active-site conformation. Phosphate addition at 0.3–0.5% improves water-holding capacity but does not inhibit cysteine protease activity at pH 5.5–6.5. Nitrite-cured systems require evaluation because ascorbate or erythorbate present at 500–1,000 mg/kg can alter the redox potential of the brine and may affect enzyme stability during extended holding. Published data for the specific interaction of MPE-PF-01 with nitrite and ascorbate in cured-meat matrices is limited; pilot batches under actual nitrite and ascorbate load are required before full-scale rollout.
Because MPE-PF-01 is not heat-stable, residual activity after cooking depends on core temperature and dwell time. At 70 °C core temperature held for 10 min, residual proteolytic activity falls below 5% of initial value; at 60 °C for 30 min, up to 20% activity may persist and cause texture softening during hot holding. This is critical for cook-in-bag products where slow cooling keeps product between 30–50 °C for extended periods. The enzyme should not be used in applications where post-cooking hold times exceed 2 h without validation. Frozen storage at −18 °C arrests hydrolysis; thawing under refrigeration at 2–4 °C restores enzymatic activity, so product tempering cycles should be controlled to avoid unintentional tenderization during distribution.
The product is supplied with a technical dossier containing lot-specific activity certificates, heavy metals and microbial analyses, and allergen statements. Papain from Carica papaya is affirmed as generally recognized as safe under FDA 21 CFR 184.1585; bromelain from Ananas comosus is referenced in FDA 21 CFR 184.1024. The product conforms to the Food Chemicals Codex specifications for enzyme preparations and is manufactured under a HACCP plan consistent with Codex Alimentarius guidance. For import into jurisdictions requiring REACH registration, the preparation is covered under the enzyme preparation entry of Regulation (EC) No 1907/2006; downstream users should confirm article or substance status with the supplier.
| Standard or regulation | Requirement | Status for MPE-PF-01 |
|---|---|---|
| FDA 21 CFR 184.1585 | Papain GRAS status | Conforms |
| FDA 21 CFR 184.1024 | Bromelain GRAS status | Conforms |
| FCC 12 | Enzyme activity, heavy metals, microbial limits | Conforms to monographs |
| ISO 6579-1:2017 | Salmonella absence | Negative per 25 g |
| ISO 4833-1:2013 | Total aerobic plate count | ≤50,000 CFU/g |
The product should not be combined with amine-based alkaline brines above pH 8.0 because activity declines rapidly and hydrolysis becomes uncontrolled. Pre-hydration in water at 20–25 °C for 10 min before brine addition prevents carrier clumping in high-shear mixers. In dry-rub formulations, preblending with salt or dextrose at a 1:10 ratio is required to achieve dispersal; direct addition to a running mixer without preblending can cause localized enzyme pockets and uneven tenderization. Storage below 25 °C in sealed barrier packaging with desiccant is required; at relative humidity above 60% the product absorbs moisture and may lose flowability. Finally, enzyme residues in meat exudate require sanitation of food-contact surfaces with an oxidizing cleaner after use, because cysteine proteases can persist and degrade proteinaceous residues in drains and vacuum lines.
